Do you want to read an article? Please log in or register.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
Heart, Artery and Coronary DiseasesTherapy and Intervention